Cette publication décrit les soins reçus par un malade diagnostiqué SLA.
L’IMT (Intestinal Microbiota Transplantation) a arrêté l’évolution de la SLA, La plupart des comorbiditésa diminué, ce qui nous oblige à conclure qu’en plus du processus neurologique primaire, l’IMT corrige généralement la plupart des comorbidités, offrant au patient une meilleure qualité de vie. Ce traitement est sans danger. Le malade a présenté des rots, qui ont cédé spontanément.
Lateral Amyotrophic Sclerosis and IntestinalMicrobiota Transplantation
Conclusion :
The IMT is beneficial in our patient and, other authors, as wellas us describes success cases, we consider that it is a procedurethat should not be disregarded. The IMT is innocuous.Our patient presented burps, which yielded spontaneously. TheLAS has not evolved in 6 months, although we must continue thefollow-up, to set a definitive criterion. Most of the comorbiditiessubsided, which forces us to conclude that in addition to theprimary neurological process, the IMT usually corrects most of thecomorbidities, providing the patient with a higher quality of life.Bases and success stories appear in the literature, which concludesthe importance of the IMT.
